A detailed history of Salem Investment Counselors Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Salem Investment Counselors Inc holds 2,975 shares of BHC stock, worth $21,985. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,975
Previous 2,975 -0.0%
Holding current value
$21,985
Previous $20,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

BUY
$7.77 - $10.61 $23,115 - $31,564
2,975 New
2,975 $31,000
Q1 2022

May 16, 2022

SELL
$21.6 - $27.79 $2,160 - $2,779
-100 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$23.0 - $29.01 $2,300 - $2,901
100 New
100 $3,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Salem Investment Counselors Inc Portfolio

Follow Salem Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.